Coherus Oncology, Inc. - CHRS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | President & CEO | A | A | 750,000.0 | 0.0 | 0.0 | 750,000.0 | View | |
| Jan 26, 2026 | President & CEO | A | A | 375,000.0 | 0.0 | 0.0 | 1,048,235.0 | View | |
| Jan 26, 2026 | Chief Financial Officer | A | A | 225,000.0 | 0.0 | 0.0 | 225,000.0 | View | |
| Jan 26, 2026 | Chief Financial Officer | A | A | 112,500.0 | 0.0 | 0.0 | 133,736.0 | View | |
| Jan 22, 2026 | Chief Financial Officer | F | D | 1,715.0 | 1.55 | 2,658.25 | 21,236.0 | View | |
| Jan 22, 2026 | President & CEO | F | D | 11,839.0 | 1.55 | 18,350.45 | 673,235.0 | View |